Literature DB >> 23095843

[Depression and neurological diseases].

D Piber1, K Hinkelmann, S M Gold, C Heesen, C Spitzer, M Endres, C Otte.   

Abstract

In many neurological diseases a depressive syndrome is a characteristic sign of the primary disease or is an important comorbidity. Post-stroke depression, for example, is a common and relevant complication following ischemic brain infarction. Approximately 4 out of every 10 stroke patients develop depressive disorders in the course of the disease which have a disadvantageous effect on the course and the prognosis. On the other hand depression is also a risk factor for certain neurological diseases as was recently demonstrated in a meta-analysis of prospective cohort studies which revealed a much higher stroke risk for depressive patients. Furthermore, depression plays an important role in other neurological diseases with respect to the course and quality of life, such as Parkinson's disease, multiple sclerosis and epilepsy. This article gives a review of the most important epidemiological, pathophysiological and therapeutic aspects of depressive disorders as a comorbidity of neurological diseases and as a risk factor for neurological diseases.

Entities:  

Mesh:

Year:  2012        PMID: 23095843     DOI: 10.1007/s00115-012-3674-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  129 in total

Review 1.  Mood disorders in multiple sclerosis and the effects on cognition.

Authors:  Anthony Feinstein
Journal:  J Neurol Sci       Date:  2006-04-27       Impact factor: 3.181

2.  Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study.

Authors:  Roseanne DeFronzo Dobkin; Lesley A Allen; Matthew Menza
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

3.  Telephone-administered psychotherapy for depression.

Authors:  David C Mohr; Stacey L Hart; Laura Julian; Claudine Catledge; Lara Honos-Webb; Lea Vella; Edwin T Tasch
Journal:  Arch Gen Psychiatry       Date:  2005-09

4.  Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Larry B Goldstein; Cheryl D Bushnell; Robert J Adams; Lawrence J Appel; Lynne T Braun; Seemant Chaturvedi; Mark A Creager; Antonio Culebras; Robert H Eckel; Robert G Hart; Judith A Hinchey; Virginia J Howard; Edward C Jauch; Steven R Levine; James F Meschia; Wesley S Moore; J V Ian Nixon; Thomas A Pearson
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

5.  Risk factors for suicide in multiple sclerosis.

Authors:  E N Stenager; N Koch-Henriksen; E Stenager
Journal:  Psychother Psychosom       Date:  1996 Mar-Apr       Impact factor: 17.659

6.  Distance delivery of mindfulness-based cognitive therapy for depression: project UPLIFT.

Authors:  Nancy J Thompson; Elizabeth Reisinger Walker; Natasha Obolensky; Ashley Winning; Christina Barmon; Colleen Diiorio; Michael T Compton
Journal:  Epilepsy Behav       Date:  2010-09-20       Impact factor: 2.937

7.  [Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany].

Authors:  O Riedel; R Dodel; G Deuschl; H Förstl; F Henn; I Heuser; W Oertel; H Reichmann; P Riederer; C Trenkwalder; H U Wittchen
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

Review 8.  Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders.

Authors:  Carmina G Bernardo; Vivek Singh; Peter M Thompson
Journal:  Expert Opin Drug Saf       Date:  2008-07       Impact factor: 4.250

9.  Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging.

Authors:  Paul E Sijens; Jop P Mostert; Roy Irwan; Jan Hendrik Potze; Matthijs Oudkerk; Jacques De Keyser
Journal:  Psychiatry Res       Date:  2008-12-30       Impact factor: 3.222

10.  Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease.

Authors:  Anne N Thorndike; Susan Regan; Kathleen McKool; Richard C Pasternak; Susan Swartz; Nancy Torres-Finnerty; Nancy A Rigotti
Journal:  Arch Intern Med       Date:  2008-01-28
View more
  1 in total

Review 1.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.